Harvest Fund Management Co., LTD Gilead Sciences, Inc. Transaction History
Harvest Fund Management Co., LTD
- $2.14 Billion
- Q4 2024
A detailed history of Harvest Fund Management Co., LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 80,889 shares of GILD stock, worth $8.42 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
80,889
Previous 57,377
40.98%
Holding current value
$8.42 Million
Previous $4.81 Million
55.35%
% of portfolio
0.35%
Previous 0.29%
Shares
20 transactions
Others Institutions Holding GILD
# of Institutions
2,072Shares Held
1.02BCall Options Held
9.63MPut Options Held
10.2M-
Black Rock Inc. New York, NY121MShares$12.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.46 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.28 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.03 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...